Nyxoah (NYXH) Liabilities and Shareholders Equity (2020 - 2026)
Nyxoah (NYXH) posted Liabilities and Shareholders Equity of $195.8 million for Q2 2026, up 71.38% on a QoQ basis from $114.3 million in Q1 2026, and up 48.53% year-over-year from $131.8 million in Q2 2025.
Powered by 
Analysis
Nyxoah (NYXH) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
Nyxoah has reported Liabilities and Shareholders Equity for 7 years, with the latest figure at $195.8 million in Q2 2026.
- On a quarterly basis, Liabilities and Shareholders Equity rose 48.53% year-over-year to $195.8 million in Q2 2026; TTM through Jun 2026 was $448.0 million, a 25.44% decrease from a year earlier, with the FY2025 full-year figure at $133.8 million, down 21.93% from the prior year.
- Liabilities and Shareholders Equity was $195.8 million for Q2 2026 at Nyxoah, up from $114.3 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $195.8 million in Q2 2026, with the low at $114.3 million in Q1 2026.
- Average Liabilities and Shareholders Equity over 5 years is $153.4 million, with a median of $155.1 million recorded in 2023.
- The sharpest annual moves came in 2024 and 2026: Liabilities and Shareholders Equity dropped 24.22% in 2024, then surged 48.53% in 2026.
- Over 5 years, Liabilities and Shareholders Equity stood at $149.0 million in 2022, then dropped by 10.36% to $133.6 million in 2023, then grew by 26.71% to $169.3 million in 2024, then declined by 18.53% to $137.9 million in 2025, then surged by 41.99% to $195.8 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $195.8 million (Q2 2026), $114.3 million (Q1 2026), and $137.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.18 Bn | 173.23 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Intuitive Surgical | 142.14 Bn | 137.06 Bn | 1.96 Bn | 20.88 Bn |
| 3 | Medtronic | 117.43 Bn | 109.23 Bn | 6.34 Bn | 93.31 Bn |
| 4 | Stryker | 105.15 Bn | 101.68 Bn | 4.50 Bn | 47.93 Bn |
| 5 | Boston Scientific | 63.37 Bn | 63.08 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 50.93 Bn | 46.79 Bn | 1.35 Bn | 13.87 Bn |
| 7 | Dexcom | 33.65 Bn | 31.71 Bn | 830.00 Mn | 6.46 Bn |
| 8 | Resmed | 32.27 Bn | 30.80 Bn | 861.22 Mn | 8.97 Bn |
| 9 | Alcon | 31.62 Bn | 30.17 Bn | 1.68 Bn | 31.10 Bn |
| 10 | Nyxoah | 63.68 Mn | -49.98 Mn | 5.33 Mn | 195.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 195.82 Mn |
| Mar 31, 2026 | 114.26 Mn |
| Dec 31, 2025 | 137.91 Mn |
| Jun 30, 2025 | 131.84 Mn |
| Mar 31, 2025 | 142.95 Mn |
| Dec 31, 2024 | 169.27 Mn |
| Sep 30, 2024 | 156.79 Mn |
| Jun 30, 2024 | 159.63 Mn |
| Mar 31, 2024 | 122.78 Mn |
| Dec 31, 2023 | 133.59 Mn |
| Sep 30, 2023 | 146.53 Mn |
| Jun 30, 2023 | 155.08 Mn |
| Mar 31, 2023 | 162.02 Mn |
| Dec 31, 2022 | 149.03 Mn |
| Sep 30, 2022 | 165.43 Mn |
| Jun 30, 2022 | 178.07 Mn |
| Mar 31, 2022 | 186.28 Mn |
| Dec 31, 2021 | 195.42 Mn |
| Dec 31, 2020 | 136.02 Mn |
API Access
Nyxoah Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NYXH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "NYXH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NYXH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();